Insiders Incyte Corporation

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 31/05/2024 BST			5-day change	1st Jan Change
57.79 ^USD	+0.86%		+0.84%	-7.96%

05-23	Deutsche Bank Initiates Incyte to Hold Rating With $55 Price Target	MT
05-21	Incyte Acquires 2 Office Buildings in Delaware	MT

Incyte Insider Sold Shares Worth $482,481, According to a Recent SEC Filing	01-05	MT
Incyte Corporation Announces Executive Changes, Effective November 1, 2023	12/09/23	CI
Insider Sell: Incyte	03/08/23	MT
Incyte's Q2 Adjusted Earnings Decline, Revenue Rises; Chief Scientific Officer Dashyant Dhanak to Depart	01/08/23	MT
Incyte Corporation Appoints Pablo J. Cagnoni, M.D. as President and Head of Research & Development, Effective June 5, 2023	08/05/23	CI
Insider Sell: Incyte	01/02/23	MT
Insider Sell: Incyte	30/01/23	MT
Insider Sell: Incyte	30/01/23	MT
Forte Biosciences, Inc. - Mr. David Gryska Appointed to Forte Biosciences Board of Directors	13/01/23	AQ
Insider Sell: Incyte	06/01/23	MT
Insider Sell: Incyte	28/12/22	MT
Insider Sell: Incyte	21/12/22	MT
Incyte Announces the Appointment of Susanne Schaffert as New Member of Its Board of Directors	04/10/22	CI
Insider Sell: Incyte	26/07/22	MT
Insider Sell: Incyte	11/07/22	MT
Insider Sell: Incyte	11/07/22	MT
Merus Regains Worldwide Rights to MCLA-145 After Incyte Opt-Out; Names Chief Commercial Officer	25/01/22	MT
Incyte Names Thomas Tray as Chief Accounting Officer	14/01/22	MT
Incyte Corporation Announces Executive Changes, Effective March 11, 2022	14/01/22	CI
Insider Sell: Incyte	11/01/22	MT

No results for this search

Incyte Corporation : Is a big change imminent?

October 26, 2023 at 03:00 pm